These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1233225)

  • 1. Plasma concentrations and urinary excretion of the antiarrhythmic quaternary ammonium compound QX-572 in man.
    Rydén L; Berlin A; Treiber LR
    Eur J Clin Pharmacol; 1975 Apr; 8(3-4):277-82. PubMed ID: 1233225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamic effects of the antiarrhythmic quaternary ammonium compound QX-572 in man.
    Rydén L; Hjalmarson A ; Kvasnicka J; Liander B
    Br Heart J; 1975 Jan; 37(1):65-73. PubMed ID: 1089426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption, metabolism and excretion of N, N-bis(phenylcarbamoylmethyl) dimethylammonium chloride (QX-572) in the rat.
    Axelson JE; Gibaldi M; Conway WD
    Xenobiotica; 1974 Oct; 4(10):585-93. PubMed ID: 4428785
    [No Abstract]   [Full Text] [Related]  

  • 4. Lidocaine and the quarternary ammonium compound QX-572 in acute myocardial infarction. A comparative study.
    Bergdahl B; Karlsson E; Magnusson JO; Sonnhag C
    Acta Med Scand; 1978; 204(4):311-4. PubMed ID: 358766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic effects of the quaternary ammonium compound QX 572 in anaesthetized cats. I. Cardiac chronotropic effects.
    Aberg G; Kopp U; Rydén L
    Acta Pharmacol Toxicol (Copenh); 1979 Feb; 44(2):91-4. PubMed ID: 760394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological effects of the antiarrhythmic agent QX-572 in the human heart with special reference to rate-induced changes in effective refractory periods.
    Rydén L; Olsson B; Kvasnicka J
    Cardiovasc Res; 1975 Jan; 9(1):81-94. PubMed ID: 1091351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the quaternary ammonium compound OX-572 on ventricular tachyarrhythmias complicating acute myocardial infarction.
    Rydén L; Hjalmarson A; Waldenström A
    Br Heart J; 1975 Apr; 37(4):426-37. PubMed ID: 1125119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a long-acting antiarrhythmic agent--QX-572--on therapy resistant ventricular tachyarrhythmias.
    Rydén L; Hjalmarson A; Wasir H; Werkö L
    Br Heart J; 1974 Aug; 36(8):811-21. PubMed ID: 4413111
    [No Abstract]   [Full Text] [Related]  

  • 9. Physiological disposition and metabolic fate of a new antiarrhythmic agent, alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine in the rat, dog, monkey, baboon, and man.
    Zacchei AG; Weidner LL; Besselaar GH; Raftery EB
    Drug Metab Dispos; 1976; 4(4):387-401. PubMed ID: 8295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative studies of the antiarrhythmic activity of prolonged action quaternary ammonium derivatives of trimecaine (G-104) and lidocaine (QX-572)].
    Kostin IaV; Fillipov AK; Grenader AK; Gendenshteĭn EI; Porotikov VI
    Farmakol Toksikol; 1987; 50(6):45-7. PubMed ID: 3436423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANTIARRHYTHMIC ACTION OF N, N-BIS (PHENYLCARBAMOYLMETHYL) DIMETHYL AMMONIUM CHLORIDE (QX-572) IN CAT AND DOG.
    KATZ RL
    Anesthesiology; 1964; 25():291-6. PubMed ID: 14156568
    [No Abstract]   [Full Text] [Related]  

  • 12. The quaternary lidocaine derivative, QX-314, produces long-lasting local anesthesia in animal models in vivo.
    Lim TK; Macleod BA; Ries CR; Schwarz SK
    Anesthesiology; 2007 Aug; 107(2):305-11. PubMed ID: 17667576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of flecainide.
    Conard GJ; Ober RE
    Am J Cardiol; 1984 Feb; 53(5):41B-51B. PubMed ID: 6364769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-pharmacokinetics relationship of quaternary ammonium compounds. Elimination and distribution characteristics.
    Neef C; Oosting R; Meijer DK
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Dec; 328(2):103-10. PubMed ID: 6527700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic studies on diponium bromide.
    Partsch G; Dunky A; Eberl R
    Int J Clin Pharmacol Res; 1983; 3(1):55-60. PubMed ID: 6679509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the bioavailability of the quaternary compound trospium chloride in man from urinary excretion data.
    Schladitz-Keil G; Spahn H; Mutschler E
    Arzneimittelforschung; 1986 Jun; 36(6):984-7. PubMed ID: 3741535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and metabolism of 14C-tinidazole in humans.
    Wood SG; John BA; Chasseaud LF; Brodie RR; Baker JM; Faulkner JK; Wood BA; Darragh A; Lambe RF
    J Antimicrob Chemother; 1986 Jun; 17(6):801-9. PubMed ID: 3733593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of lorcainide in man: a new antiarrhythmic agent.
    Klotz U; Müller-Seydlitz P; Heimburg P
    Clin Pharmacokinet; 1978; 3(5):407-18. PubMed ID: 699462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and antiarrhythmic efficacy of intravenous ajmaline in ventricular arrhythmia of acute onset.
    Köppel C; Wagemann A; Martens F
    Eur J Drug Metab Pharmacokinet; 1989; 14(2):161-7. PubMed ID: 2591421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.